BlackRock’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,844,951
| Closed | -$250M | – | 5973 |
|
|
2022
Q3 | $250M | Buy |
4,844,951
+207,299
| +4% | +$8.57M | 0.01% | 1313 |
|
|
2022
Q2 | $115M | Buy |
4,637,652
+343,317
| +8% | +$7.57M | ﹤0.01% | 1922 |
|
|
2022
Q1 | $108M | Sell |
4,294,335
-32,152
| -0.7% | -$904K | ﹤0.01% | 2099 |
|
|
2021
Q4 | $158M | Sell |
4,326,487
-102,067
| -2% | -$3.58M | ﹤0.01% | 1905 |
|
|
2021
Q3 | $75.7M | Sell |
4,428,554
-230,843
| -5% | -$3.6M | ﹤0.01% | 2387 |
|
|
2021
Q2 | $62.4M | Sell |
4,659,397
-317,198
| -6% | -$7.81M | ﹤0.01% | 2554 |
|
|
2021
Q1 | $255M | Buy |
4,976,595
+171,898
| +4% | +$10.3M | 0.01% | 1551 |
|
|
2020
Q4 | $298M | Buy |
4,804,697
+332,263
| +7% | +$19M | 0.01% | 1314 |
|
|
2020
Q3 | $245M | Buy |
4,472,434
+184,550
| +4% | +$9.94M | 0.01% | 1222 |
|
|
2020
Q2 | $247M | Buy |
4,287,884
+378,900
| +10% | +$20.6M | 0.01% | 1207 |
|
|
2020
Q1 | $157M | Sell |
3,908,984
-204,172
| -5% | -$8.67M | 0.01% | 1336 |
|
|
2019
Q4 | $163M | Buy |
4,113,156
+47,245
| +1% | +$830K | 0.01% | 1647 |
|
|
2019
Q3 | $27.6M | Buy |
4,065,911
+213,036
| +6% | +$1.6M | ﹤0.01% | 2629 |
|
|
2019
Q2 | $35.8M | Buy |
3,852,875
+1,202,155
| +45% | +$13.9M | ﹤0.01% | 2531 |
|
|
2019
Q1 | $36.8M | Sell |
2,650,720
-78,981
| -3% | -$903K | ﹤0.01% | 2440 |
|
|
2018
Q4 | $29.8M | Sell |
2,729,701
-73,020
| -3% | -$770K | ﹤0.01% | 2515 |
|
|
2018
Q3 | $35.4M | Buy |
2,802,721
+80,783
| +3% | +$973K | ﹤0.01% | 2568 |
|
|
2018
Q2 | $35.8M | Buy |
2,721,938
+155,172
| +6% | +$1.86M | ﹤0.01% | 2541 |
|
|
2018
Q1 | $34.9M | Sell |
2,566,766
-175,841
| -6% | -$1.81M | ﹤0.01% | 2478 |
|
|
2017
Q4 | $16.3M | Sell |
2,742,607
-31,586
| -1% | -$217K | ﹤0.01% | 2885 |
|
|
2017
Q3 | $20.6M | Buy |
2,774,193
+444,377
| +19% | +$3.69M | ﹤0.01% | 2793 |
|
|
2017
Q2 | $21.8M | Buy |
2,329,816
+174,471
| +8% | +$1.28M | ﹤0.01% | 2742 |
|
|
2017
Q1 | $15.7M | Buy |
2,155,345
+2,139,920
| +13,873% | +$15.4M | ﹤0.01% | 2897 |
|
|
2016
Q4 | $114K | Buy |
15,425
+12,139
| +369% | +$87.4K | ﹤0.01% | 2477 |
|
|
2016
Q3 | $20K | Hold |
3,286
| – | – | ﹤0.01% | 3291 |
|
|
2016
Q2 | $14K | Buy |
3,286
+1,261
| +62% | +$4.73K | ﹤0.01% | 3353 |
|
|
2016
Q1 | $5K | Buy |
2,025
+406
| +25% | +$1.48K | ﹤0.01% | 3378 |
|
|
2015
Q4 | $13K | Buy |
1,619
+1,000
| +162% | +$7.08K | ﹤0.01% | 2779 |
|
|
2015
Q3 | $4K | Hold |
619
| – | – | ﹤0.01% | 3095 |
|
|
2015
Q2 | $5K | Hold |
619
| – | – | ﹤0.01% | 3138 |
|
|
2015
Q1 | $5K | Buy |
+619
| New | +$4.84K | ﹤0.01% | 3041 |
|
|
2014
Q2 | – | Sell |
-859
| Closed | -$6K | – | 3247 |
|
|
2014
Q1 | $6K | Buy |
859
+224
| +35% | +$1.56K | ﹤0.01% | 3018 |
|
|
2013
Q4 | $4K | Hold |
635
| – | – | ﹤0.01% | 3099 |
|
|
2013
Q3 | $4K | Hold |
635
| – | – | ﹤0.01% | 3044 |
|
|
2013
Q2 | $9K | Buy |
+635
| New | +$8.23K | ﹤0.01% | 2721 |
|
Other funds holding CCXI
BlackRock's CCXI Position: Q4 2022 in Review
BlackRock sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 4,844,951 shares — an estimated $250M sold.
BlackRock first reported a position in CCXI in Q2 2013 and held it in 35 quarters. The position peaked at $298M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- BlackRock reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- BlackRock sold 4,844,951 ChemoCentryx, Inc. shares in Q4 2022, an estimated $250M.
- BlackRock first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 35 quarters.
- BlackRock's ChemoCentryx, Inc. position peaked at $298M in Q4 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.